Human iPSC-Derived Chimeric Antigen Receptor Macrophages to Modulate Inflammation and Combat Tau-Induced Pathology

Project: Research project

Project Details

Description

Human iPSC-Derived Chimeric Antigen Receptor Macrophages to Modulate Inflammation and Combat Tau-Induced Pathology
StatusActive
Effective start/end date1/15/2512/31/25

Funding

  • NIH NAT'L INSTITUTE ON AGING (NIA)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.